{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:55Z","timestamp":1707524275094},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,20]]},"DOI":"10.7759\/cureus.14574","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T11:23:10Z","timestamp":1618917790000},"source":"Crossref","is-referenced-by-count":0,"title":["Azithromycin in the Successful Management of COVID-19: A Family Physician\u2019s Perspective"],"prefix":"10.7759","author":[{"given":"Leonid","family":"Tafler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Danilevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Weekly epidemiological update - 22 December. (2020). Accessed. December 24, 2020: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update---22-december-2020."},{"key":"ref2","unstructured":"Therapeutic management of patients with COVID-19. (2020). Accessed. December 17, 2020: https:\/\/www.covid19treatmentguidelines.nih.gov\/therapeutic-management\/.."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/13814788.2020.1820479","article-title":"Lessons on the COVID-19 pandemic, for and by primary care professionals worldwide","volume":"26","author":"Rawaf S","year":"2020","unstructured":"Rawaf S, Allen LN, Stigler FL, Kringos D, Yamamoto HQ, van Weel C. Lessons on the COVID-19 pandemic, for and by primary care professionals worldwide. Eur J Gen Pract. 2020, 26:129-33. 10.1080\/13814788.2020.1820479","journal-title":"Eur J Gen Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaa067","article-title":"Telehealth transformation: COVID-19 and the rise of virtual care","volume":"27","author":"Wosik J","year":"2020","unstructured":"Wosik J, Fudim M, Cameron B, et al.. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020, 27:957-62. 10.1093\/jamia\/ocaa067","journal-title":"J Am Med Inform Assoc"},{"key":"ref5","article-title":"Outpatient management of COVID-19: rapid evidence review","volume":"102","author":"Cheng A","year":"2020","unstructured":"Cheng A, Caruso D, McDougall C. Outpatient management of COVID-19: rapid evidence review. Am Fam Physician. 2020, 102:478-86.","journal-title":"Am Fam Physician"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: transmission, prevention, and potential therapeutic opportunities","volume":"508","author":"Lotfi M","year":"2020","unstructured":"Lotfi M, Hamblin MR, Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020, 508:254-66. 10.1016\/j.cca.2020.05.044","journal-title":"Clin Chim Acta"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.06.067","article-title":"SARS-CoV-2 detection, viral load and infectivity over the course of an infection","volume":"81","author":"Walsh KA","year":"2020","unstructured":"Walsh KA, Jordan K, Clyne B, et al.. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J Infect. 2020, 81:357-71. 10.1016\/j.jinf.2020.06.067","journal-title":"J Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173643","article-title":"Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic","volume":"890","author":"Bhandari R","year":"2021","unstructured":"Bhandari R, Khanna G, Kuhad A. Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic. Eur J Pharmacol. 2021, 890:173643. 10.1016\/j.ejphar.2020.173643","journal-title":"Eur J Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1813024","article-title":"Azithromycin in the treatment of COVID-19: a review","volume":"19","author":"Echeverr\u00eda-Esnal D","year":"2021","unstructured":"Echeverr\u00eda-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco ME, De-Antonio Cusc\u00f3 M, Ferr\u00e1ndez O, Horcajada JP, Grau S. Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther. 2021, 19:147-63. 10.1080\/14787210.2020.1813024","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31863-8","article-title":"Azithromycin for severe COVID-19","volume":"396","author":"Oldenburg CE","year":"2020","unstructured":"Oldenburg CE, Doan T. Azithromycin for severe COVID-19. Lancet. 2020, 396:936-7. 10.1016\/S0140-6736(20)31863-8","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00394-19","article-title":"Azithromycin protects against Zika virus Infection by upregulating virus-induced type I and III interferon responses [IN PRESS]","author":"Li C","year":"2019","unstructured":"Li C, Zu S, Deng YQ, et al.. Azithromycin protects against Zika virus Infection by upregulating virus-induced type I and III interferon responses [IN PRESS]. Antimicrob Agents Chemother. 2019, 10.1128\/AAC.00394-19","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/srep28698","article-title":"Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients","volume":"6","author":"Menzel M","year":"2016","unstructured":"Menzel M, Akbarshahi H, Bjermer L, Uller L. Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients. Sci Rep. 2016, 6:28698. 10.1038\/srep28698","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00933-3","article-title":"Azithromycin for COVID-19: more than just an antimicrobial?","volume":"40","author":"Bleyzac N","year":"2020","unstructured":"Bleyzac N, Goutelle S, Bourguignon L, Tod M. Azithromycin for COVID-19: more than just an antimicrobial?. Clin Drug Investig. 2020, 40:683-6. 10.1007\/s40261-020-00933-3","journal-title":"Clin Drug Investig"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson PG","year":"2017","unstructured":"Gibson PG, Yang IA, Upham JW, et al.. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017, 390:659-68. 10.1016\/S0140-6736(17)31281-3","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/49488-azithromycin-in-the-successful-management-of-covid-19-a-family-physicians-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:16Z","timestamp":1707507136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/49488-azithromycin-in-the-successful-management-of-covid-19-a-family-physicians-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.14574","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,20]]}}}